172 related articles for article (PubMed ID: 7652675)
1. [Do radiotherapy and immediate orchiectomy yield comparable results as radical prostatectomy, adjuvant irradiation and orchiectomy in patients with stage D1 of prostatic carcinoma?].
Wiegel T
Strahlenther Onkol; 1995 Aug; 171(8):480-1. PubMed ID: 7652675
[No Abstract] [Full Text] [Related]
2. Adjuvant endocrine therapy after radical prostatectomy for stage D1 prostate carcinoma.
Stein A; deKernion JB
Semin Urol; 1990 Aug; 8(3):184-9. PubMed ID: 2119049
[No Abstract] [Full Text] [Related]
3. [Treatment of prostatic cancer].
Shimazaki J; Fuse H; Akimoto S; Akakura K
Gan To Kagaku Ryoho; 1988 Feb; 15(2):212-8. PubMed ID: 3341783
[TBL] [Abstract][Full Text] [Related]
4. Combined surgery and immediate adjuvant hormonal treatment for stage D1 adenocarcinoma of the prostate: Mayo Clinic experience.
Zincke H
Semin Urol; 1990 Aug; 8(3):175-83. PubMed ID: 2399386
[No Abstract] [Full Text] [Related]
5. [Adjuvant radiotherapy following radical prostatectomy--results, acute and late toxicity].
Wiegel T; Bressel M; Baumann M; Schwarz R; Hübener KH
Strahlenther Onkol; 1993 Mar; 169(3):152-8. PubMed ID: 8465249
[TBL] [Abstract][Full Text] [Related]
6. Radical retropubic prostatectomy plus orchiectomy versus orchiectomy alone for pTxN+ prostate cancer: a matched comparison.
Ghavamian R; Bergstralh EJ; Blute ML; Slezak J; Zincke H
J Urol; 1999 Apr; 161(4):1223-7; discussion 1227-8. PubMed ID: 10081874
[TBL] [Abstract][Full Text] [Related]
7. [Adjuvant treatment after radical prostatectomy in prostatic carcinoma (pT3 or pTxN+): prognostic factors and results].
Zincke H
Praxis (Bern 1994); 1997 Nov; 86(46):1825-32. PubMed ID: 9454284
[TBL] [Abstract][Full Text] [Related]
8. [Survival after radical retropubic prostatectomy in patients with poorly differentiated prostatic carcinoma].
Weigel C
Strahlenther Onkol; 1996 Jul; 172(7):404-5. PubMed ID: 8693408
[No Abstract] [Full Text] [Related]
9. [Pro and contra -- adjuvant therapy in locoregional advanced prostatic carcinoma after radical prostatectomy].
Ohlmann C; Heidenreich A
Aktuelle Urol; 2004 Sep; 35(5):372-4. PubMed ID: 15478268
[No Abstract] [Full Text] [Related]
10. Long-term results of adjuvant hormonal therapy plus radiotherapy following radical prostatectomy for patients with pT3N0 or pT3N1 prostate cancer.
Miyake H; Sakai I; Harada K; Hara I; Eto H
Int J Urol; 2004 Jun; 11(6):397-401. PubMed ID: 15157209
[TBL] [Abstract][Full Text] [Related]
11. Postradical prostatectomy irradiation in carcinoma of the prostate. American College of Radiology. ACR Appropriateness Criteria.
Perez CA; Beyer DC; Blasko JC; Forman JD; Hussey DH; Lee WR; Paryani SB; Pollack A; Potters L; Roach M; Scardino P; Schellhammer P; Leibel S
Radiology; 2000 Jun; 215 Suppl():1419-39. PubMed ID: 11037557
[No Abstract] [Full Text] [Related]
12. [Pro and contra -- adjuvant therapy in locoregional advanced prostatic carcinoma after radical prostatectomy].
Hammerer P
Aktuelle Urol; 2004 Sep; 35(5):371-2. PubMed ID: 15384001
[No Abstract] [Full Text] [Related]
13. [Recurrence following radical surgery for prostatic cancer. Analysis of clinical, biological and anatomo-pathological prognostic factors].
Feyaerts A; Delrée A; Lorge F; Opsomer RJ; Wese FX; Van Cangh PJ; Draguet AP; Cosyns JP
Acta Urol Belg; 1997 Mar; 65(1):11-8. PubMed ID: 9245198
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant therapy after radical prostatectomy: clinical considerations.
Mitra A; Khoo V
Surg Oncol; 2009 Sep; 18(3):247-54. PubMed ID: 19285386
[TBL] [Abstract][Full Text] [Related]
15. Prostatic cancer--what to do? Staging and prognostic factors in the primary therapy decision.
Faul P
Eur Urol; 1992; 22(2):89-98. PubMed ID: 1478236
[No Abstract] [Full Text] [Related]
16. The role of radical prostatectomy in patients with clinically localized prostate cancer and a prostate-specific antigen level >20 ng/ml.
Bastide C; Kuefer R; Loeffler M; de Petriconi R; Gschwend J; Hautmann R
Prostate Cancer Prostatic Dis; 2006; 9(3):239-44. PubMed ID: 16832384
[TBL] [Abstract][Full Text] [Related]
17. Node-positive prostate cancer. American College of Radiology. ACR Appropriateness Criteria.
Lee WR; Pollack A; Perez CA; Beyer DC; Blasko JC; Forman JD; Hussey DH; Paryani SB; Potters L; Roach M; Scardino P; Schellhammer P; Leibel S
Radiology; 2000 Jun; 215 Suppl():1413-8. PubMed ID: 11037556
[No Abstract] [Full Text] [Related]
18. Predictors of secondary cancer treatment in patients receiving local therapy for prostate cancer: data from cancer of the prostate strategic urologic research endeavor.
Grossfeld GD; Li YP; Lubeck DP; Broering JM; Mehta SS; Carroll PR
J Urol; 2002 Aug; 168(2):530-5. PubMed ID: 12131303
[TBL] [Abstract][Full Text] [Related]
19. Role of early adjuvant hormonal therapy after radical prostatectomy for prostate cancer.
Zincke H; Lau W; Bergstralh E; Blute ML
J Urol; 2001 Dec; 166(6):2208-15. PubMed ID: 11696737
[TBL] [Abstract][Full Text] [Related]
20. [Adjuvant medical treatment or radiotherapy following radical prostatectomy or curative radiotherapy].
Guy L
Bull Cancer; 2007 Jul; 94(7 Suppl):F15-20. PubMed ID: 17845989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
